GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (BUE:TMO) » Definitions » Capex-to-Operating-Income

Thermo Fisher Scientific (BUE:TMO) Capex-to-Operating-Income : 0.21 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Thermo Fisher Scientific Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Thermo Fisher Scientific's Capital Expenditure for the three months ended in Mar. 2024 was ARS-292,347.51 Mil. Its Operating Income for the three months ended in Mar. 2024 was ARS1,425,510.02 Mil.

Hence, Thermo Fisher Scientific's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.21.


Thermo Fisher Scientific Capex-to-Operating-Income Historical Data

The historical data trend for Thermo Fisher Scientific's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Capex-to-Operating-Income Chart

Thermo Fisher Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.19 0.25 0.26 0.20

Thermo Fisher Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.16 0.17 0.21 0.21

Competitive Comparison of Thermo Fisher Scientific's Capex-to-Operating-Income

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific's Capex-to-Operating-Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Capex-to-Operating-Income falls into.



Thermo Fisher Scientific Capex-to-Operating-Income Calculation

Thermo Fisher Scientific's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-533919) / 2641798.002
=0.20

Thermo Fisher Scientific's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-292347.505) / 1425510.024
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thermo Fisher Scientific  (BUE:TMO) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Thermo Fisher Scientific Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Thermo Fisher Scientific (BUE:TMO) Business Description

Address
168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).